NEW YORK (GenomeWeb) – Qiagen announced today that it plans to issue $400 million in senior, unsecured cash settled convertible notes convertible into common shares.

The company, which set the size of the issuance at $350 million before increasing it shortly thereafter to $400 million, said the number of ordinary shares underlying the notes will be up to 8.5 million, representing approximately 3.8 percent of its current outstanding shares.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.